Background:Diabetes Mellitus produces long-term damage and failure of various tissues, in particular, diabetes-induced neural damage. Changes of neuromuscular transmission would contribute to the progressive weakness in diabetic patients; Electrophysiological studies are of recognized use in the confirmation of alterations of neuromuscular transmission and helping to differentiate them from other conditions. The current study was performed to evaluate the integrity of neuromuscular junction (NMJ) in patients with type 2 diabetes using repetitive nerve stimulation (RNS) technique and assessment of acetylcholine receptors antibodies in the serum. Patients and Methods:This cross-sectional study involved 103 patients with type 2 diabetes mellitus. The entire subjects met certain inclusion and exclusion criteria to exclude other possible contributing factors of neuropathy. All subjects completed a pre-requested questionnaire, then physical and neurological examinations were done, routine nerve conduction study, repetitive nerve stimulation and assessment of acetylcholine receptors antibodies were performed. Results:Among 103 patients with type 2 DM patients 56 of them were diagnosed as peripheral polyneuropathy however, the rest (47) their NCS result were normal, 11 (10.7%) of them showed positive decrement test, All those with positive decrement test they have also peripheral polyneuropathy, serum acetylcholine receptor antibody test was negative in all the participants (those with positive and negative decrement test). Conclusions:This preliminary study implies that type 2 diabetes contributes to the neuromuscular junction dysfunction. Further studies are indicated to explain the pathophysiology and mechanisms responsible for positive decrement test in type 2 diabetic patients.
yperglycemia associated with diabetes mellitus (DM) produces long-term damage and failure of various tissues 1 . In particular, diabetes-induced neural damage is a predominant form of neuropathy 2 . Changes of neuromuscular transmission would contribute to the progressive muscle weakness in diabetics 3 .
Therefore, the goal of this study was to further explore the effects of diabetes on the neuromuscular junction (NMJ).
Neuromuscular junction (NMJ) disorders are characterized by fluctuating muscle weakness, depending on the site of neuromuscular transmission failure, NMJ disorders have been classified as: (A) presynaptic (e.g., Lambert-Eaton myasthenic syndrome), (B) synaptic (e.g., cholinesterase inhibitor toxicity), and (C) post-synaptic (e.g., myasthenia gravis) 4 . 11 (10.7%) of them showed positive decrement test ( Figure 2 ). As demonstrated in Table 2 , and 3. Also, Figure 4 and 5 significant decrements (more than 10%) of compound muscle action potential amplitude between the first and fourth motor response were observed. Increment test was negative in all participants. All those with positive decrement test they have also peripheral polyneuropathy; however, the rest of diabetic patients showed normal RNS, the gender distribution among those with positive decrement test were 7 females and 4 males. Estimation of serum acetylcholine receptor antibodies was done for all the patients and the results were negative in all the participants (those with positive and negative decrement test). 
DISCUSSION

